Flaxseed Mucilage (IQP-LU-104) Reduces Body Weight in Overweight and Moderately Obese Individuals in a 12-week, Three-arm, Double-blind, Randomized and Placebo-controlled Clinical Study
Introduction: The aim of this study was to evaluate the benefit and tolerability of two dosages of a proprietary flaxseed mucilage (IQP-LU-104) in reducing body weight in overweight and moderately obese individuals. Methods: In a double-blind, randomized, placebo-controlled, bi-center trial, 108 par...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2022-02-01
|
Series: | Obesity Facts |
Online Access: | https://www.karger.com/Article/FullText/522082 |